Bronchial Spasm Market Size

  • Report ID: 4394
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Bronchial Spasm Market Size

Bronchial Spasm Market size is expected to reach revenue by the end of 2033, witnessing around CAGR of 5% during the forecast period, i.e., 2023-2033. Further, the market generated noteworthy revenue in the year 2022. The growth of the market can primarily be ascribed to the rising cases of asthma across the globe. Based on the statistics provided by the World Health Organization (WHO), it was noticed that almost 262 million people were living with asthma in 2019 causing 455,000 deaths worldwide.

Global bronchial spasm market trends such as, the spiking number of fungal, viral, and bacterial infections of the lungs and skyrocketing prevalence of dust, pet, pollen, and other sorts of allergens are projected to influence the growth of the market positively over the forecast period. allergies are anticipated to be the 6th leading cause of death, for instance, over 45 million Americans are projected to be affected by allergies every year. Moreover, bronchial spasm is a condition in which the bronchi (airways in the lungs) get inflamed or tighten. The bronchial spasm can cause coughing, wheezing, and other respiratory diseases. Therefore, such factors are anticipated to push the growth of the market over the forecast period.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4394
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing prevalence of fungal infection and rising cases of COPD across the globe are estimated to majorly boost the market growth.

The market is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2023-2033.

Shortage of medication and skilled medical professionals is estimated to challenge the market growth.

The market in North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Sunovion Pharmaceuticals Inc., Merck & Co., Inc., Viatris Inc., Pfizer Inc., The Bristol-Myers Squibb Company, Sanofi S.A, Teva Pharmaceutical Industries Ltd. and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by treatment type, diagnosis, cause, end-user, and region.

The short-acting bronchodilators segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample